PPLPHARMA logo

Piramal Pharma Limited

F&O
PPLPHARMA·NSE·
213.03 -1.37 (-0.64%)
Market Cap28318.79 Cr
PE Ratio31.93
Volume29,09,325
Day High - Low216.12 - 210.50
52W High-Low220.36 - 132.30
DocStoX Score
4.0/10
Weak
Fair Value
Sign in to see
ROE
-3.58%
Weak
P/E
31.93x
Fair
Debt / Equity
0.70
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250NIFTY PHARMA
Day210.50
216.12
52W132.30
220.36
DocStoX take

Supported by momentum (7.5), but held back by quality (1.9). Momentum looks strong at 7.5, but that is offset by quality at 1.9 and growth at 2.2. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.0
/10
Weak
Quality
Weak
ROE -3.6%
Valuation
Rich
P/E 31.9×
Growth
Flat
Revenue +6.2% 5Y CAGR
Risk
Moderate
D/E 0.70
Momentum
Strong
92% of 52-week range

At a glance

Market Cap
₹28,319 Cr
52W High / Low
₹220 / ₹132
Dividend Yield
0.07%
Promoter Holding
34.80%
EPS (TTM)
₹6.67
Book Value
₹61.40

Key highlights

  • Loss-making in some of the last 4 years
  • Quality is weak (1.9/10)
0 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

PIRAMAL PHARMA LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.